Nasdaq, Inc. reports developments across its market infrastructure, index, listings, data and financial technology businesses. Recurring updates include quarterly results, monthly trading volumes, U.S. cash equities and options activity, listing trends, capital returns, and changes to Nasdaq Global Indexes such as the Nasdaq-100 Index.
Company news also covers Financial Technology products and client activity, including Nasdaq Verafin, AxiomSL, Calypso, surveillance tools, cloud deployments and AI-enabled workflow capabilities. Other recurring themes include index-linked product partnerships, private market indexes, tokenized equity settlement, extended trading initiatives, dividends, share repurchases and governance or market-rule developments tied to Nasdaq’s regulated exchange operations.
The Nasdaq Stock Market announced that trading in Statera Biopharma resumed on August 26, 2022, at 7:10 a.m. Eastern Time. This follows a halt in trading that occurred a day earlier, on August 25, 2022, at 11:01:52 a.m. Eastern Time. The resumption of trading indicates regulatory clearance, but further details regarding the reasons for the halt or any specific developments regarding Statera Biopharma were not provided in the announcement.
The Nasdaq Stock Market (NDAQ) announced the resumption of trading for Smart Powerr Corp. (CREG) on August 25, 2022, at 2:30 p.m. ET. Trading was halted earlier on the same day at 11:07:03 a.m. ET. This indicates a significant event for investors and traders interested in CREG's stock, as trading halts and resumptions can impact stock liquidity and price movements. For further details about Smart Powerr Corp., stakeholders are advised to contact the company directly or check the Nasdaq website under the company’s symbol.
On August 25, 2022, trading in Smart Powerr Corp. (Nasdaq: CREG) was halted by the Nasdaq Stock Market at 11:07:03 A.M. ET. The halt, initiated at a price of $3.5762, was due to a request for additional information from the company. Trading will remain suspended until the company fulfills the Nasdaq's requirements. Shareholders are advised to monitor company news directly or search for updates under the company’s symbol on the Nasdaq website.
On August 25, 2022, trading in Statera Biopharma, Inc. (Nasdaq: STAB) was halted by Nasdaq at 11:01:52 A.M. ET for "additional information requested". The last sale price before the halt was $0.215. Trading will remain suspended until the company fulfills Nasdaq's information request.
Investors are advised to check the Nasdaq website for further developments regarding the company.
Summary not available.
The Nasdaq Stock Market announced the resumption of trading for Vinco Ventures, Inc. (Nasdaq: BBIG) at 12:30 p.m. Eastern Time on August 16, 2022, following a trading halt initiated on August 4, 2022. The halt was effective from 1:44:39 p.m. Eastern Time.
This decision reflects the market's ongoing regulatory scrutiny, which emphasizes the importance of compliance in ensuring investor confidence. For further details, stakeholders are encouraged to contact the company directly or check the Nasdaq website under the company's trading symbol.
Summary not available.
The Nasdaq Stock Market (NDAQ) announced a trading halt for Vinco Ventures, Inc. (BBIG) on August 4, 2022, at 01:44:39 PM ET. The trading was suspended for 'additional information requested' at a last sale price of $0.7117. Trading will remain halted until Vinco Ventures has completely fulfilled Nasdaq’s request for further information. This action may indicate potential concerns regarding the company’s compliance or operational metrics.
Nasdaq (NDAQ) announced its monthly trading volumes for July 2022. The data sheet detailing these volumes is available on their investor relations website. This report serves as an important metric for investors, reflecting the trading activity and market dynamics during the month. Nasdaq continues to position itself as a leader in technology solutions for capital markets.
Summary not available.